机构

• 计算技术研究所 [4]

采集方式

• OAI收割 [4]

内容类型

• 期刊论文 [4]

发表日期

• 2024 [2]
• 2021 [2]

学科主题

筛选

浏览/检索结果: 共4条，第1-4条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent chordoma patient with molecular alterations treated with Palbociclib 期刊论文  OAI收割 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 卷号: 150, 期号: 2, 页码: 9 作者:  Zhong, Nanzhe;  Yu, Dong;  Yang, Minglei;  Lu, Xingyi;  Zhang, Qiangzu   |  收藏  |  浏览/下载：0/0  |  提交时间：2024/05/20 Chordoma  Palbociclib  Genomic features  Drug resistance   RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding 期刊论文  OAI收割 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 卷号: 43, 期号: 1, 页码: 15 作者:  Lin, Ying;  Wu, Yun;  Zhang, Qiangzu;  Tu, Xunwei;  Chen, Sufang   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/20 Non-small cell lung cancer  Brain metastasis  RPTOR  SPHK2  S1P   DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations 期刊论文  OAI收割 EBIOMEDICINE, 2021, 卷号: 69, 页码: 11 作者:  Yang, Mei;  Fan, Yanhui;  Wu, Zhi-Yong;  Gu, Jin;  Feng, Zhendong   |  收藏  |  浏览/下载：63/0  |  提交时间：2021/12/01 HER2-negative breast cancer  Germline rare coding mutations  Damage assessment of genomic mutations (DAGM)  Risk assessment  Activity profiles of signalling pathways (APSP)  HER2 signalling pathway  Immune suppression   Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer 期刊论文  OAI收割 CANCER RESEARCH, 2021, 卷号: 81, 期号: 4, 页码: 1 作者:  Yang, Mei;  Fan, Yanhui;  Wu, Zhi-Yong;  Feng, Zhendong;  Zhang, Qiangzu   |  收藏  |  浏览/下载：51/0  |  提交时间：2021/12/01